Two studies show higher anti-S titers in those with previous infection and very strong T-cell responses
Axillary Adenopathy Reported After Recent COVID-19 Vaccination
Management approach to these findings includes axillary ultrasound if clinical concern persists six weeks after final dose of vaccine
AstraZeneca COVID-19 Vaccine Easy to Update in Response to Variants
Oxford team working on modifying vaccine to fight new variants, expects new version to be available in the fall
Walmart Expands COVID-19 Vaccination Program
Company will use COVID-19 vaccines supplied by the U.S. Centers for Disease Control and Prevention
J&J COVID-19 Vaccine Granted Emergency Use Authorization
The single-dose Ad26 vaccine is now the third COVID-19 vaccine to be granted an EUA
Online Portal Guides Users to COVID-19 Vaccination Sites Nationwide
VaccineFinder has been expanded to include more than 20,000 COVID-19 vaccination sites
COVID-19 Vaccine Makers Planning for Variants
Pfizer, BioNTech in discussions with regulators about testing an adapted version of their vaccine
Pfizer, Moderna Tell Congress a Big Jump in Vaccine Supply Is Coming
By end of March, Pfizer and Moderna expect to have delivered a total of 220 million vaccine doses to the U.S. government
Nationwide Study Shows BNT162b2 mRNA Vaccine Is Effective
In mass vaccination setting, vaccine is effective for symptomatic COVID-19, hospitalization, severe disease, death
FDA Review Reveals J&J COVID-19 Vaccine Safe, Effective
Advisory panel set to meet Friday to recommend whether the agency should authorize the shot for emergency use